Bioperfectus Cervical Cancer Screening Total PCR Solution embraces the WHO 90-70-90 target. It helps realize the key pillar- 70% of women screened using a high-performance test by age 35 and again by age 45.
Bioperfectus deliver strong financial performance in the first half of 2022
Emerging infectious diseases significantly threaten global public health and socioeconomic security. The majority of emerging infectious disease outbreaks are mainly caused by zoonotic /vector-borne viruses.
BioPerfectus is pleased to announce that we now officially recognized as the valued membership of International Federation of Clinical Chemistry and Laboratory Medicine(IFCC).
At Bioperfectus, the excellent experience of our customers is our goal and the key to our job. Last Wednesday, we completed online technical training for our distribution local support in the Asia Pacific region. The webinar covers insightful training on Bioperfectus Nucleic Acid Extraction System, Nucleic Acid Extraction Kit, Real-Time PCR System, and product demonstration on the newly launched SAW-96 Nucleic Acid Extraction Workstation.
Jiangsu BioPerfectus Technologies Co., Ltd. (hereinafter referred to as “BioPerfectus”) is pleased to announce that Monkeypox Virus Real Time PCR Kit has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) and is now officially available for Great Britain and Northern Ireland market.
With over 600 thousand new cases and more than half that would lead to death each year, cervical cancer is listed as the fourth most frequent cancer among women worldwide.
Sexually transmitted diseases (STDs), also known as sexually transmitted infections (STIs), are infections caused by organisms that can be transmitted from one person to another through sexual activity and intimate contact.
Bioperfectus is pleased to announce a strategic partnership with ELITechGroup S.p.A for monkeypox virus testing across Europe. The Monkeypox Virus Real Time PCR Kit from Bioperfectus in combination with the fully automated sample-to-result ELITe InGenius and BeGenius instruments from ELITechGroup will address the needs of major reference laboratories, hospitals, and disease control centers in Europe.
Bioperfectus, together with our partner in France, R-Biopharm France, has completed the clinical validation of the Bioperfectus Monkeypox Virus Real Time PCR Kit in l’institut de recherche biomédicale des armées (the Institute of Biomedical Research of the Armed Forces, IRBA), an organization established by the Army Health Service (SSA) in France.
